Avatrombopag (Doptelet)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 19:24, 29 October 2017 by Jwarner (talk | contribs)
Jump to navigation Jump to search

Mechanism of action

Thrombopoietin receptor agonist

Preliminary data

Autoimmune thrombocytopenic purpura (ITP)

  1. Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. link to original article PubMed

Also known as

  • Code names: YM477, AKR 501
Retrieved from "https://hemonc.org/w/index.php?title=Avatrombopag_(Doptelet)&oldid=18723"